Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Molecular Epidemiology and Drug Resistance Pattern of Carbapenem-Resistant Klebsiella Pneumoniae Isolates From Iran Publisher Pubmed



Jafari Z1, 2 ; Harati AA1 ; Haeili M3 ; Kardanyamchi J4 ; Jafari S5 ; Jabalameli F1 ; Meysamie A6 ; Abdollahi A7 ; Feizabadi MM1, 8
Authors

Source: Microbial Drug Resistance Published:2019


Abstract

The emergence and dissemination of carbapenem-resistant Klebsiella pneumoniae (CRKP) isolates and their involvement in several nosocomial outbreaks are of high concern. This study was conducted to investigate the genetic relatedness and molecular determinants of carbapenem resistance in 100 CRKP isolates. Susceptibility to carbapenems as well as other antibiotics was determined by using disk diffusion method. The Modified Hodge test was performed for detection of carbapenemase production. The minimum inhibitory concentrations of selected antibiotics were determined by broth microdilution method. The presence of bla OXA-48 , bla KPC , bla NDM , and bla VIM carbapenemase genes was examined by PCR, and clonal relatedness of CRKP isolates was investigated by pulsed-field gel electrophoresis (PFGE) analysis. bla OXA-48 was the most frequent carbapenemase gene (72%), followed by bla NDM (31%). None of the isolates harbored bla KPC and bla VIM genes. PFGE separated the majority of isolates into 10 clusters, including the major clusters A and B, carrying bla OXA-48 , and clusters C and D, carrying bla NDM , and 4 isolates had a unique PFGE pattern. An increased rate of colistin resistance (50%) was detected among the isolates. Tigecycline was found to be the most active agent against CRKP isolates. Our results revealed that high prevalence of bla OXA-48 and bla NDM carbapenamses and resistance to colistin are alarming threats, necessitating an immediate action to prevent the spread of carbapenem-colistin-resistant K. pneumoniae isolates in Iran. © 2019, Mary Ann Liebert, Inc., publishers.
Other Related Docs